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Many interventional devices are currently part of our arma-
mentarium for the treatment of obstructed arteries (1). Some
of these devices result in remodeling of the obstructing
material, whereas others alter luminal obstruction by remov-
ing the tissue rather than displacing, cracking, crushing or
compressing it. One of the exciting new tools in the area of
tissue removal is the atherectomy device. The prototype of
this device is the Simpson atherotome consisting of a motor-
driven cutter rotating at 2,000 rpm that slowly "shaves
away" or "scoops out" obstructing material. The excised
material is deposited in a distal collection chamber.
The present study. In this issue of the Journal, Johnson et
al. (2) report the first histologic observations on excised
peripheral arterial tissue from transluminal atherectomy
procedures in 100 patients. Three major categories of tissue
were found: 1) atherosclerotic plaque (with or without
thrombus), 2) intimal fibrous proliferation (fibrous intimal
hyperplasia), and 3) thrombus only. Of native lesions treated
with the atherectomy device, 88% of the tissue samples were
typical atherosclerotic plaque, 9% were fibrous intimal thick-
ening with medial calcinosis and 3% consisted of thrombus
only. Among postinterventional lesions (restenosis after
primary balloon angioplasty or primary atherectomy, or
both) treated with subsequent atherectomy, 75% of those
excised consisted of intimal fibrous proliferation and 25%
were classic atherosclerotic plaque identical to samples
recovered from native lesions.
Conclusions derived from the study. At least four clini-
cally relevant observations are apparent from the morpho-
logic-histologic data presented by Johnson et al. (2):
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1. Intimal fibrous proliferation ("restenosis") lesions
reported in necropsy patients with preceding balloon angio-
plasty procedures are histologically identical to those in
living patients. In the past, some investigators have sug-
gested that the intimal fibrous hyperplasic lesions of resteno-
sis might be unique to necropsy patients. Johnson et al. (2)
are the first to document the identical nature of angioplasty
restenosis tissue in living and in necropsy patients.
2. Clinical and angiographic restenosis occurs after pri-
mary atherectomy procedures. As a potential alternative to
balloon angioplasty or as a complementary method of ther-
apy, transluminal atherectomy does not appear to be free of
the problem of restenosis. In the study by Johnson et al. (2),
16 (18%) of 89 patients initially treated with atherectomy
returned with restenosis, and 3 (27%) of 11 patients treated
with atherectomy for restenosis after previous balloon an-
gioplasty returned with a second restenosis.
3. Restenosis lesions occurring after balloon angioplasty
do not consist exclusively of intimal fibrous proliferation
tissue. At least 25% of the restenosis tissue removed by
transluminal atherectomy is atherosclerotic plaque indistin-
guishable from the native lesion (Fig. 1). Atherectomy
specimens from restenosis lesions consisting only of athero-
sclerotic plaque can be explained in several ways: 1) the
initial stenotic atherosclerotic lesion was inadequately, in-
sufficiently or superficially dilated; 2) the initial angioplasty
mechanism was concentric or eccentric vessel stretching; 3)
the restenosis lesion represents accelerated development of
atherosclerotic plaque; or 4) various combinations of these
conditions exist. Accelerated development of atheroscle-
rotic plaque at the site of restenosis seems an unlikely
explanation, because the time interval from the interven-
tional procedure to restenosis is only a few months and the
restenosis material consists of densely fibrotic and calcified
material (i.e., "old plaque"). Different morphologic sub-
strates for restenosis (atherosclerotic plaque, intimal fibrous
proliferation, stretching of eccentric lesions) suggest that
different treatment strategies may be necessary for each type
of restenosis lesion.
4. Arterial vessel healing after angioplasty or atherec-
tomy, or both, is nonspecific and appears to be independent
of the mechanism by which the arterial injury or disruption
initially occurred. Johnson et al. (2) compared the intimal
fibrous proliferation material at restenosis sites from previ-
ous primary balloon angioplasty and previous primary
atherectomy procedures and found them histologically sim-
ilar in cellularity, vascularity, degree of fibrosis, content of
inflammatory cells and presence of thrombus. Furthermore,
four restenosis lesions in which both angioplasty and
atherectomy were the primary interventional therapy
showed no histologic differences from those of either proce-
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Figure 1. Possible morphologic expla-
nations for "restenosis" material re-
moved by transluminal atherectomy
devices. Atherectomy specimens
consist of combined atherosclerotic
plaque with intimal fibrous prolifera-
tion, intimal fibrous proliferation
only, atherosclerotic plaque only,
atherosclerotic plaque with thrombus
or thrombus only. The dashed line
indicates the original luminal surface
before atherectomy. L = lumen.
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Figure 2. Morphologic comparison of restenosis le-
sions following primary transluminal balloon angio-
plasty versus primary transluminal atherectomy. Res-
tenosis following atherectomy may have a similar,
shorter ("accelerated") or longer ("delayed," "re-
set") interval from intervention to clinical restenosis.
The restenosis tissue in either intervention is intimal
fibrous proliferation. The dashed line indicates the
original luminal surface before atherectomy. L =
lumen.
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dure alone. Thus, it appears that angioplasty, atherectomy
and perhaps other interventional procedures associated with
intimal fibrous proliferation restenosis could have a common
method of treatment or prevention because the morphologic
response to vessel injury is the same.
Unresolved issues. Although the report by Johnson et al.
(2) addresses several topics of restenosis and atherectomy
procedures, many issues concerning restenosis following
atherectomy procedures remain unresolved: Is the interval
of time from the atherectomy procedure to clinical resteno-
sis, similar to or shorter or longer than that of primary
balloon angioplasty? How much arterial media is removed at
atherectomy? Does the exposure of more arterial media
during atherectomy procedures than during angioplasty pro-
cedures result in "accelerated" restenosis (Fig. 2)? Does
increased luminal cross-sectional area created by the actual
removal ofobstructing native lesions override the potentially
adverse effect of greater medial layer exposure and, thus,
"delay" or "reset" the timing of clinical restenosis (Fig. 2)?
These and other questions will be the subject of future
studies.
Conclusions. The clinical usefulness of the atherectomy
procedure is not limited to its role in removal of obstructing
material in symptomatic patients. Atherectomy can be a tool
in obtaining human restenosis tissue for tissue culture or for
the preparation of monoclonal blocking agents to smooth
muscle cells or other "specific restenosis cells." It can aid in
evaluating differences in restenosis tissue after various phar-
macologic therapies for preventing restenosis. It can also be
a tool for the removal of large intimal flaps or occluding
thrombus in acute or abrupt occlusions after balloon angio-
plasty.
Johnson et al. (2) are to be congratulated on their report
and for providing new insights into the processes of resteno-
sis after angioplasty and raising new and challenging ques-
tions for future research with transluminal atherectomy.
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